GL1X · GenesisL1 explorer

MolNFT v1 · #184476 · protein

Crystal structure of JNK3 in complex with light-activated covalent inhibitor mr-II-249 with both non-covalent and covalent binding modes (compound 4)

7ORE · Mitogen-activated protein kinase 10: “Crystal structure of JNK3 in complex with light-activated covalent inhibitor mr-II-249 with both non-covalent…”. X-ray diffraction, 1 ligand (0EI), 2 pockets (best druggability 0.76). MolNFT v1…

PDB
7ORE
Type
protein
Length
352 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 10
EC
2.7.11.24
UniProt
P53779
Ligands
0EI
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 10 (EC 2.7.11.24)protein35238% helix, 16% strandP53779

Ligands and binding sites

  • 0EI · 4-(dimethylamino)-N-[(5Z)-9-[[4-[5-(4-fluorophenyl)-3-methyl-2-methylsulfanyl-imidazol-4-yl]pyridin-2-yl]amino]-11,12-dihydrobenzo[c][1,2]benzodiazocin-2-yl]butanamide · ligand · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17560.760.80830EI, EDO
2630.360.7813empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7ORE · Crystal structure of JNK3 in complex with light-activated covalent inhibitor MR-II-249… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.